Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Dan Gebremedhin, MD
PARTNER, FLARE CAPITAL
Investors' Perspectives: Digital Health Trends and Investment Thesis in 2023 and Beyond
Asha George, DrPH
EXECUTIVE DIRECTOR, BIPARTISAN COMMISSION ON BIODEFENSE
Enhancing Public Health Preparedness through Policy and Partnership
Deb Geraghty, PhD
CEO AND PRESIDENT, ANOKION INC.
Early to Mid-Stage Biotechs: Creating Partnerships to Enhance Program Value and Accelerate Therapies
Laurie Gery, MBA
GLOBAL HEAD OF BUSINESS DEVELOPMENT, VACCINES, SANOFI
Sanofi
Swiftwater, Pennsylvania, United States
Hamza Ghadyali, PhD
SENIOR AI SPECIALIST, SAS
The Art and Science of Applying AI in the Race to Protect Global Public Health
Oren Gilad, PhD
CEO, APREA THERAPEUTICS
Aprea Therapeutics, Inc.
Doylestown, Pennsylvania, United States
Adam Gilbert, PhD
EXECUTIVE DIRECTOR AND EXTERNAL ACCELERATOR LEAD, PFIZER
From Serendipity to Rational Design, Redefining the Rules of Molecular Glue Discovery
Placeholder Photo
Ryan Gill, PhD
CEO, CO-FOUNDER, ARTISAN BIO
Artisan Bio
Louisville, Colorado, United States
Christoph Glaetzer
GLOBAL HEAD OF MARKET ACCESS, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Bringing Value Assessments into the 21st Century: A Multi-Stakeholder Perspective
New York City, New York, United States
Jacob Glanville, PhD
FOUNDER & CEO, CENTIVAX
Centivax
South San Francisco, California, United States